An Intact Overexpressed E-cadherin/α,β-Catenin Axis Characterizes the Lymphovascular Emboli of Inflammatory Breast Carcinoma

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer Research

• Publication date

  2001-07-01

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis

  2000cited by this paper
• Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases.

  1999cited by this paper
• A novel human xenograft model of inflammatory breast cancer.

  1999cited by this paper
• Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic β tumor cells

  1999cited by this paper
• Cadherin function in junctional complex rearrangement and posttranslational control of cadherin expression.

  1999cited by this paper
• Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer.

  1998cited by this paper
• E-cadherin Regulates Anchorage-independent Growth and Survival in Oral Squamous Cell Carcinoma Cells*

  1998cited by this paper
• Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay.

  1998cited by this paper
• Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma histogenesis.

  1998cited by this paper
• Tumor cell intravasation alu-cidated: the chick embryo opens the window.

  1998cited by this paper
• Calcium binding and homoassociation of E-cadherin domains.

  1997cited by this paper
• Cell Adhesion: Review The Molecular Basis of Tissue Architecture and Morphogenesis

  1997cited by this paper
• Lateral self‐assembly of E‐cadherin directed by cooperative calcium binding

  1997cited by this paper
• The human myoepithelial cell is a natural tumor suppressor.

  1997cited by this paper
• Molecular and functional analysis of cadherin-based adherens junctions.

  1997cited by this paper
• Expression of a dominant negative cadherin mutant inhibits proliferation and stimulates terminal differentiation of human epidermal keratinocytes.

  1996cited by this paper
• Alloreactive monoclonal antibodies select Kd molecules with different peptide profiles.

  1996cited by this paper
• H–cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer

  1996cited by this paper
• The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses

  1996cited by this paper
• A Metastasis Caught in the Act

  1996cited by this paper
• Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.

  1995cited by this paper
• Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness.

  1994cited by this paper
• Prognostic factors in inflammatory breast cancer and therapeutic implications.

  1994cited by this paper
• Selective disruption of E-cadherin function in early Xenopus embryos by a dominant negative mutant.

  1994cited by this paper
• Reduction of E-Cadherin Levels and Deletion of the α-Catenin Gene in Human Prostate Cancer Cells

  1993cited by this paper
• A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis.

  1993cited by this paper
• Description of a spheroid model for the study of radiation and chemotherapy effects on hypoxic tumor cell populations.

  1992cited by this paper
• Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

  1979cited by this paper
• The significance of hematogenous tumor cell clumps in the metastatic process.

  1976cited by this paper

• Seltenheiten beim Mammakarzinom

  2025cites this paper
• Lymphovascular Tumoral Emboli in Inflammatory Breast Cancer Result from Haptotaxis-Mediated Encircling Lymphangiogenesis

  2024cites this paper
• Unique Cohorts of Salivary Gland Cancer Cells as an in-vitro Model of Circulating Tumor Cells

  2024cites this paper
• Tumor Dormancy Within the Lymphovascular Embolus Is Regulated by Multiple Metabolism-signaling Pathways

  2024cites this paper
• Geometric tumor embolic budding characterizes inflammatory breast cancer

  2022cites this paper
• Lymphovascular Invasion as a Prognostic Factor in Non-Metastatic Adenocarcinoma of Esophagogastric Junction After Radical Surgery

  2020cites this paper
• Decorin, a novel negative modulator of E-cadherin in inflammatory breast cancer

  2020cites this paper
• Hypoxia, partial EMT and collective migration: Emerging culprits in metastasis

  2020cites this paper
• EMT, MET, Plasticity, and Tumor Metastasis.

  2020cites this paper
• The Role of p120catenin in the Initiation and Dissemination of Pancreatic Cancer

  2019cites this paper
• High Expression of Plakoglobin Promotes Metastasis in Invasive Micropapillary Carcinoma of the Breast via Tumor Cluster Formation

  2019cites this paper
• Gestational trophoblastic neoplasms (GTNs) do not display epithelial-to-mesenchymal transition (EMT) features

  2019cites this paper
• Inflammatory Breast Cancer: Diagnostic, Molecular and Therapeutic Considerations

  2019cites this paper
• Stromal fibroblasts induce metastatic tumor cell clusters via epithelial–mesenchymal plasticity

  2019cites this paper
• Inflammatory breast cancer: The pathologists' perspective.

  2018cites this paper
• Sunitinib induces early histomolecular changes in a subset of renal cancer cells that contribute to resistance

  2018cites this paper
• 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs

  2018cites this paper
• International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference

  2018cites this paper
• Circulating tumor microemboli: Progress in molecular understanding and enrichment technologies.

  2018cites this paper
• CSF-1/CSF-1R axis is associated with epithelial/mesenchymal hybrid phenotype in epithelial-like inflammatory breast cancer

  2018cites this paper
• Inflammatory breast cancer: a model for investigating cluster-based dissemination

  2017cites this paper
• Use of αv Integrin Linked to GFP to Image Molecular Dynamics in Trafficking Cancer‐Cell Emboli

  2017cites this paper
• Insulin‐like growth factor‐1 signaling is responsible for cathepsin G‐induced aggregation of breast cancer MCF‐7 cells

  2017cites this paper
• EMT and MET: necessary or permissive for metastasis?

  2017cites this paper
• The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease.

  2016cites this paper
• Paradoxical E-cadherin increase in 5FU-resistant colon cancer is unaffected during mesenchymal-epithelial reversion induced by γ-secretase inhibition.

  2016cites this paper
• Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening

  2015cites this paper
• HDAC6 as a Therapeutic Candidate in the Treatment of Inflammatory Breast Cancers

  2015cites this paper
• A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic Process

  2015cites this paper
• Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells

  2015cites this paper
• Spherical Cancer Models in Tumor Biology1

  2015cites this paper
• IBC as a Rapidly Spreading Systemic Disease: Clinical and Targeted Approaches Using the Neoadjuvant Model.

  2015cites this paper
• Inflammatory Breast Cancer: Mini Review

  2015cites this paper
• Establishment and Characterization of a New Cell Line of Canine Inflammatory Mammary Cancer: IPC-366

  2015cites this paper
• Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer

  2015cites this paper
• Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management

  2015cites this paper
• Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.

  2015cites this paper
• Prognostic value of lymphocyte vascular density and e-cadherin in inflammatory breast cancer

  2014cites this paper
• Neutrophil Cathepsin G, but Not Elastase, Induces Aggregation of MCF-7 Mammary Carcinoma Cells by a Protease Activity-Dependent Cell-Oriented Mechanism

  2014cites this paper
• Ectodomain-Specific E-Cadherin Antibody Suppresses Skin SCC Growth and Reduces Tumor Grade: A Multitargeted Therapy Modulating RTKs and the PTEN–p53–MDM2 Axis

  2014cites this paper
• Contribution of ER and NF-κB to endocrine resistance in inflammatory breast cancer

  2014cites this paper
• Evaluation of E-cadherin, β-catenin and vimentin protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients.

  2014cites this paper
• Collagen attachment to the substrate controls cell clustering through migration

  2014cites this paper
• Targeted Deletion of ER Chaperone GRP94 in the Liver Results in Injury, Repopulation of GRP94-Positive Hepatocytes, and Spontaneous Hepatocellular Carcinoma Development in Aged Mice

  2014cites this paper
• Molecular analysis of circulating tumour cells—biology and biomarkers

  2014cites this paper
• Differential expression of E-cadherin, β-catenin, and Lewis x between invasive hydatidiform moles and post-molar choriocarcinomas

  2013cites this paper
• Inflammatory breast cancer (IBC): clues for targeted therapies

  2013cites this paper
• Epigallocatechin-3-Gallate Inhibits Stem-Like Inflammatory Breast Cancer Cells

  2013cites this paper
• The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin

  2013cites this paper
• Modeling and characterization of inflammatory breast cancer emboli grown in vitro

  2013cites this paper
• The Down-Regulation of Notch1 Inhibits the Invasion and Migration of Hepatocellular Carcinoma Cells by Inactivating the Cyclooxygenase-2/Snail/E-cadherin Pathway In Vitro

  2013cites this paper
• Monoclonal Antibody against the Ectodomain of E-Cadherin (DECMA-1) Suppresses Breast Carcinogenesis: Involvement of the HER/PI3K/Akt/mTOR and IAP Pathways

  2013cites this paper
• Target Therapy in Inflammatory Breast Cancer

  2013cites this paper
• FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.

  2013cites this paper
• Pathology of Inflammatory Breast Cancer

  2013cites this paper
• Gene Signatures of Inflammatory Breast Cancer: Epithelial Plasticity and a Cancer Stem Cell Phenotype

  2013cites this paper
• The Molecular Biology of Inflammatory Breast Cancer

  2013cites this paper
• Clinical & Experimental Pathology

  2012cites this paper
• Inflammatory Breast Cancer Stem Cells: Contributors to Aggressiveness, Metastatic Spread and Dormancy

  2012cites this paper
• Morphophenotypic characteristics of intralymphatic cancer and stromal cells susceptible to lymphogenic metastasis

  2012cites this paper
• Singular v Dual inhibition of SNF2L and its isoform, SNF2LT, have similar effects on DNA Damage but opposite effects on the DNA Damage Response, Cancer Cell Growth Arrest and Apoptosis

  2012cites this paper
• New Therapeutic Targets in Inflammatory Breast Cancer

  2012cites this paper
• Cyclin D1, E‐cadherin and beta‐catenin expression in FIGO Stage IA cervical squamous carcinoma: diagnostic value and evidence for epithelial–mesenchymal transition

  2012cites this paper
• Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer.

  2012cites this paper
• Systemic and Targeted Therapy

  2012cites this paper
• Models of Inflammatory Breast Cancer

  2012cites this paper
• Pathology: Histomorphometrical Features of IBC – Angiogenesis, Lymphangiogenesis, and Tumor Emboli

  2012cites this paper
• Cathepsin G Induces Cell Aggregation of Human Breast Cancer MCF-7 Cells via a 2-Step Mechanism: Catalytic Site-Independent Binding to the Cell Surface and Enzymatic Activity-Dependent Induction of the Cell Aggregation

  2012cites this paper
• Inflammatory breast cancer: what we know and what we need to learn.

  2012cites this paper
• E-cadherin's dark side: possible role in tumor progression.

  2012cites this paper
• Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments.

  2012cites this paper
• Investigation of Telomerase Activity in Inflammatory and Non Inflammatory Breast Cancer

  2012cites this paper
• Molecules That Drive the Invasion and Metastasis of Inflammatory Breast Cancer

  2012cites this paper
• Genomic Profiling of Pre-Clinical Models of Inflammatory Breast Cancer Identifies a Signature of Epithelial Plasticity and Suppression of TGFò Signaling

  2012influential citation
• Molecular characterization of E-cadherin glycosylation in cancer.

  2011cites this paper
• Ganoderma lucidum (Reishi) Inhibits Cancer Cell Growth and Expression of Key Molecules in Inflammatory Breast Cancer

  2011cites this paper
• Inflammatory breast cancer.

  2011cites this paper
• The lymphovascular embolus of inflammatory breast cancer exhibits a Notch 3 addiction

  2011cites this paper
• International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.

  2011cites this paper
• Genomic and Proteomic Pathway Mapping Reveals Signatures of Mesenchymal-Epithelial Plasticity in Inflammatory Breast Cancer

  2011cites this paper
• Unexpected functional similarities between gatekeeper tumour suppressor genes and proto-oncogenes revealed by systems biology

  2011cites this paper
• Early detection and treatment of certain malignant tumors

  2011cites this paper
• An update on inflammatory breast cancer

  2011cites this paper
• Lung adenocarcinoma cells floating in lymphatic vessels resist anoikis by expressing phosphorylated Src

  2010cites this paper
• Biology and management of inflammatory breast cancer

  2010cites this paper
• ERα signaling through slug regulates E-cadherin and EMT

  2010cites this paper
• Imaging and Analysis of 3D Tumor Spheroids Enriched for a Cancer Stem Cell Phenotype

  2010cites this paper
• E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking.

  2010cites this paper
• Inflammatory Breast Cancer: The Disease, the Biology, the Treatment

  2010cites this paper
• Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer

  2010cites this paper
• Inflammatory and Locally Advanced Breast Cancer

  2010cites this paper
• Aggressive progression of breast cancer with microscopic pulmonary emboli possessing a stem cell‐like phenotype independent of its origin

  2010cites this paper
• The function of Tiam1 in tumor cell biology

  2009cites this paper
• Dynamics of cell-cell junctions in keratinocytes

  2009cites this paper
• Inflammatory breast cancer.

  2009cites this paper
• Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer

  2009cites this paper
• Gain in cellular organization of inflammatory breast cancer: A 3D in vitro model that mimics the in vivo metastasis

  2009cites this paper
• Inhibition of Expression of the Chromatin Remodeling Gene, SNF2L, Selectively Leads to DNA Damage, Growth Inhibition, and Cancer Cell Death

  2009cites this paper
• Molecular targets for treatment of inflammatory breast cancer

  2009cites this paper
• Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer

  2009cites this paper